Today’s AI Top Pick: GENI
6/25/2026 · Contrarian screen · a free sample of K3vl4r’s AI-curated picks.
AI-ranked from a screened shortlist, with entry strategy, targets, and risks.
View the live GENI price forecast →
Genius Sports (GENI) is the cleanest contrarian-bounce setup in the pool: a real $1.51B market-cap business that has pulled back ~19.5% off recent highs into a model-bullish window, with multi-timeframe agreement that is uniformly constructive. The 1d forecast is the standout — fc_short +55.11%, fc_mid +48.21%, fc_long +53.27% — and the 4h (mid +64.44%) and 1wk (mid +84.49%) horizons confirm. Near-term bullish reads 1.0, kronos_probability is 1, and the 1h pos_in_21bar_range is just 4.3% (not chasing), while the 1wk pos is mid-range at 59.39% — a healthy 'pulled in but not broken' configuration. Fundamentals are the best in the field by a wide margin: fundamental_score 5.0, analyst recom 1.21 (strong buy), fwdPe 12.98, salesYoY +33.31%, epsNextY +1601.51%, instOwn 87.09%, targetUpsidePct +80.9%. RSI 45.4 says the dip cooled momentum but didn't crater it. News flow is genuinely positive — Insider Monkey 'Best Small Cap Stocks to Buy for the Long Term,' Seeking Alpha 'Perfect Blend,' and a fresh LIGA MX/Polymarket deal — i.e. real catalysts, not just oversold mean reversion. Why today: the 1d, 4h and 1wk forecasts all point materially higher, the 1h pos at 4.3% of range means we are buying near intraday support rather than chasing a green print, and there is no landmine headline (compare AVAV — lawsuits + restated $89M earnings; SEGG — short-seller calling it a 'fake company'; SRXH — 60-to-1 reverse split; MNTS — $75M ATM dilution; TRAW — HC Wainwright downgrade; LASE — CEO leave of absence; HTZ — recom 3.5 and falling on the day). Cleanest signal + cleanest tape + best fundamentals = best risk/reward. The 1h fc_mid of -18.74% is the one wart, suggesting a possible chop into entry, which is why the plan is to scale rather than market-buy the open. But by the daily horizon the model expects ~+48–55%, and the weekly horizon expects +84% — that's the trade we're getting paid for.
- 1h fc_mid of -18.74% suggests near-term chop/retest — entry can get whipped before the bounce engages
- Sports-betting/marketing comp risk: revenue tied to client (DraftKings/leagues) ad budgets; profitMargin still -22.27% and operMargin -16.52%
- Drawdown of -19.5% is mild — if macro risk-off accelerates, downside to $5.00 (next 1wk range support) is real
- shortFloat 8.38% is modest but a failed bounce could trigger fresh momentum shorts
- perfYtd -48.64% and perfYear -43.85% mean the longer-term trend is still down; this is a counter-trend trade, not a trend trade
| # | Symbol | Verdict | Score | Read |
|---|---|---|---|---|
| 1 | GENI | BUY NOW | 8.6 | Best fundamentals (fund_score 5, fwdPe 12.98, recom 1.21) + clean 1d/4h/1wk forecasts + positive news; mid-range entry, not chasing. |
| 2 | SY | BUY NOW | 7.9 | RSI 26.85, pos_in_range 0% across 4h/1d/1wk, 1wk fc_long +101.61%, recom 1 — textbook oversold reversal candidate. |
| 3 | ARBE | BUY NOW | 7.7 | Huge weekly forecasts (+336/+598%), positive growth-stock coverage, RSI 32.4, bottom-of-range entry. |
| 4 | PRCT | BUY NOW | 7.2 | $1.19B mcap, salesYoY +29%, 1wk fc_mid +204%, positive 'Best Robotics' coverage; near_term_bullish 0.2 is the catch. |
| 5 | SNAL | BUY PULLBACK | 6.8 | fwdPe 2.29, fund_score 4.25, all-tf bullish, but 1h pos 88% — wait for a dip back to $0.58. |
| 6 | NXL | BUY NOW | 6.5 | 1d fc_long +146%, recom 1, recent positive clinical data, pos_in_range 0% on 4h/1d/1wk. |
| 7 | PBK | BUY NOW | 6.4 | 1d fc_mid +96.59%, fund_score 3, real $242.3M procurement news, recom 1. |
| 8 | KTA-USD | BUY NOW | 6.3 | Crypto with 1d fc_long +172%, near_term_bullish 1.0; no fundamentals to judge but signal is clean. |
| 9 | ANNA | BUY PULLBACK | 6.1 | Actually profitable (pe 18.18, profitMargin 17.43%), salesYoY +1533%, but forecasts more modest (1d fc_mid +45%). |
| 10 | GRML | BUY PULLBACK | 5.9 | RSI 29.4, positive drilling contract news, 1wk fc_long +591%, but illiquid and no fundamentals visibility. |
| 11 | CXAI | BUY PULLBACK | 5.7 | 1wk fc_long +4922% and revenue triple narrative, but near_term_bullish 0.2 and 1h fc_long -24%. |
| 12 | CRV-USD | BUY PULLBACK | 5.6 | Crypto contrarian, 1d fc_mid +81.67%, but broader crypto derivatives signal still bearish. |
| 13 | TRAW | WAIT | 5.3 | Forecasts huge but HC Wainwright downgrade to Neutral with $1 PT undercuts thesis. |
| 14 | SST | BUY PULLBACK | 5.3 | Insider buying + 1d fc_mid +118%, but salesYoY -31% and fund_score -0.75. |
| 15 | GELS | WAIT | 5.0 | 1d fc_mid +52% and clinical progress, but operMargin -3267% and fund_score -2; tiny $7.4M mcap. |
| 16 | TWAV | WAIT | 4.9 | 1d fc_long +70%, but 1wk forecast -1133% and $4.5M mcap make it a casino bet. |
| 17 | NCPL | WAIT | 4.8 | 1wk fc_long +6629% looks absurd; $4.36M mcap, perfYear -86%, profit margin -3804%. |
| 18 | SENS | WAIT | 4.7 | salesYoY +71.9% and 1d fc_long +32%, but 1wk forecasts are negative and fund_score -0.25. |
| 19 | HTZ | WAIT | 4.6 | 1d fc_short +90% looks great but recom 3.5 (hold), and stock is actively falling today on negative coverage. |
| 20 | MNTS | AVOID | 4.4 | $75M ATM dilution program just announced and 1d fc_short -40.68% — exactly the wrong setup. |
| 21 | BAK | WAIT | 4.4 | RSI 28.75 oversold and Elliott debt accumulation hint, but restructuring talks = equity risk; 1d fc_short -3.25%. |
| 22 | FOXX | WAIT | 4.3 | 1d fc_short +65% but Q3 loss widened, fund_score -2, no analyst coverage. |
| 23 | LASE | AVOID | 4.2 | CEO 3-month leave of absence + 1h fc_long -61.87% / 1wk fc_long -27.6% — broken setup. |
| 24 | CODX | WAIT | 4.1 | 1d fc_mid +129% but 1wk fc_short -62.5% and 1h forecasts all negative — too whippy. |
| 25 | AIFF | WAIT | 4.0 | 1wk fc_long +956% but fc_short -162%; fund_score -3 and $18M mcap. |
| 26 | AVAV | AVOID | 3.9 | Lawsuits + restated earnings on $89M error — strong forecasts undercut by material legal/accounting risk. |
| 27 | AIM | AVOID | 3.8 | ps 115.25, profitMargin -14123%, operMargin -10072% — pure lottery ticket even if RSI 24.5 hints at oversold bounce. |
| 28 | CRDF | AVOID | 3.7 | fund_score -3.25, ps 162.5, shortFloat 28.97%, perfYear -60.6% — broken biotech. |
| 29 | SRXH | AVOID | 3.3 | 60-to-1 reverse split announced — overrides forecast strength; capital-structure red flag. |
| 30 | SEGG | AVOID | 2.6 | White Diamond short report calling it a 'fake company' — non-starter regardless of forecast. |
Get AI top picks & forecasts on any stock
K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.
Create your free account →Already a member? Sign in · Join our Discord